SCHEMBL16981072

SCHEMBL16981072

Cc1cc(-c2c(C)oc3c(C)c(C)c(C)c(C)c3c2=O)cc(C)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.38
▸ BCL2 P10415 2/20 0.36
▸ MCL1 Q07820 2/20 0.36
▸ BAD Q92934 1/20 0.36
▸ MAPT P10636 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ALDH2 P05091 1/20 0.31
▸ HPGD P15428 1/20 0.30
▸ STAT6 P42226 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14286794 0.79 ALOX5 (0.37) ALDH1A1CYP3A4ADORA3MAPTKMT2A
SCHEMBL12852133 0.75 BCL2 (0.47) ALDH1A1CYP3A4BCL2MCL1BAD
SCHEMBL16981110 0.71 GAA (0.32) ALDH1A1CYP3A4MAPTGAAKDM4E
SCHEMBL14134418 0.70 ADORA3 (0.32) ADORA3ALDH2
SCHEMBL12249331 0.65 KDM4E (0.31) GAAKDM4E
SCHEMBL27554470 0.62 ALDH1A1 (0.48) ALDH1A1CYP3A4ADORA3MAPTGAA
SCHEMBL9945368 0.62 — —
SCHEMBL12440792 0.61 ALDH2 (0.30) ALDH2
SCHEMBL12558040 0.60 KDM4E (0.40) ALDH1A1CYP3A4MAPTGAAKDM4E
SCHEMBL31155758 0.60 KDM4E (0.40) ALDH1A1CYP3A4MAPTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150216167-A1 SELECTIVE INHIBITION OF C4-PEP CARBOXYLASES HEINRICH HEINE UNIVERSITAT DUSSELDORF (DE) 2015-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150216167-A1 SELECTIVE INHIBITION OF C4-PEP CARBOXYLASES CBR3, GRHPR, PCK1 ALDH1A1 4064/4885CYP3A4 101/4885ADORA3 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback